Precision Bio Says Federal Court Stays IP Litigation by Cellectis | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Precision Biosciences said today that a federal court has stayed patent litigation brought against it by Cellectis.

Following a "non-final" decision by the US Patent and Trademark Office in the spring, the US District Court for the Eastern District of North Carolina has ordered all proceedings in the case be suspended until the USPTO has finished its reexamination of US Patents 6,610,545 and 7,309,605, to which Cellectis holds exclusive rights.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.